European Equity pre-Market Summary - 17th September 2026: European equity futures are indicative of a slightly firmer open; Bilfinger sinks after cutting guidance

Stories: Anglo American (AAL LN): The European Commission warned MMG’s proposed acquisition of Anglo American’s Brazilian nickel business could reduce competition and raise European stainless-steel costs. Raiffeisen Bank (RBI AV), -3.2%: Grizzly Research is short Raiffeisen Bank, stating that they have uncovered USD 1.191bln in Russian trade. Novartis (NOVN SW), +1%: Co. discontinued development of VHB937 in ALS following results from the phase 2 Astrals study, which did not meet its primary or secondary endpoints. Roche (ROP SW), +0.7%: Co. announces that the phase 3 CELESTIMO study, met its primary endpoint. Earnings/Updates: Bollore (BOL FP): In its H1’26 report, Revenue rose from the prior, whilst Net Income fell short. Bilfinger (GBF GY), -9.5%: Co. cuts its FY26 outlook; now sees revenue EUR 5.3-5.7bln (prev. guided EUR 5.4-5.9bln) IPO: German Defence: KNDS is reportedly considering pushing back its IPO, as advisors point to the recent stock market performance of listed defence companies, Bloomberg reports. Broker Moves: Dassault Systemes (DSY FP) downgraded to Underperform from Neutral at BNP Paribas The numbers after the Co. & ticker are the pre-market indication via Tradegate